Bayer Extends Afrin Line With First OTC Oxymetazoline Spray In US For Children Under 6

Children’s Afrin regular and no-drip formulations reach US stores with consumers having choices between dozens of oxymetazoline nasal sprays available under an FDA OTC monograph. But products indicated for children was limited to one, Mucinex Childrens Stuffy Nose, and it’s for children 6 and up.

• Source: Shutterstock

Bayer AG doubles the number of children’s OTC oxymetazoline nasal sprays available in the US while offering the first indicated for children younger than 6 with the launch of Children’s Afrin Extra Moisturizing Stuffy Nose Spray in regular and no-drip formulations.

“As the leader of acute medicated nasal sprays, it was the right time for Afrin to begin expanding into the...

More from Ingredients & Safety

More from HBW Insight

Expanded Distribution In US Helps Drive Up BioGaia Sales

 
• By 

Swedish probiotics player BioGaia is reaping the benefits of increased marketing investments and distribution in the US.

Self-Testing Kits Need To Be Regulated Like OTCs, UK Researchers Argue

 
• By 

Concerns raised by two recent studies prompt UK researchers to argue for greater regulation with regards to direct-to-consumer test kits.

Senate HELP Committee Adds Sunscreen Regulation Overhaul To OMUFA Reauthorization

 
• By 

OMUFA reauthorization bill including amendment with sunscreen regulation provisions passed by Senate committee, which also approved other provisions not included in House OMUFA bill.